Entering text into the input field will update the search result below

ENZC Enzolytics, Inc.
Stock Price & Overview

$0.05-0.0018 (-3.67%)4:00 PM 09/20/23
Pink Current Info | $USD | Post-Market: $0.04 -0.00 (-5.50%) 4:01 PM


Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Prev. Close

Quant Ranking

Company Profile

Enzolytics, Inc. logo
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company’s proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
  • 2000 North Central Expressway
  • Plano, TX, 75074
  • United States
Phone Number
972 292 9414
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.